Seres Therapeutics Inc (MCRB) Q2 2019 Earnings Call Transcript
MCRB earnings call for the period ending June 30, 2019.
Seres Therapeutics
MCRB
MCRB
$3.31
$0.34
11.4%
BATS BZX Real Time Price as of August 19, 2019, 4:00 p.m. EDT
View Interactive MCRB Charts
Seres Therapeutics, Inc.
News & Analysis: Seres Therapeutics
Here's Why Seres Therapeutics Stock Soared Today
A new collaboration with AstraZeneca could give microbiome-based medicine a big lift.
Seres Therapeutics Inc (MCRB) Q4 2018 Earnings Conference Call Transcript
MCRB earnings call for the period ending December 31, 2018.
Why Seres Therapeutics Inc. Stock Is Tanking Today
Results from a phase 1 study failed to impress investors.
Why GoPro, Barnes & Noble, and Seres Therapeutics Jumped Today
These stocks climbed even though the broader market eased lower. Find out why.
Here's What's Lifting Seres Therapeutics Inc.'s Stock Price Today
A second chance granted by the FDA could be just what the company needs.
Why Seres Therapeutics Inc. Shares Are Jumping Today
Investors bid up shares in response to a bullish analyst note.
3 Big Losers This Week in the Stock Market
Investors of Seres Therapeutics, Ford Motor Company, and Infinera could probably use a stiff drink after this week.
Why Seres Therapeutics Inc. Is Being Obliterated Today
Shares plunged in reaction to important study results that missed the mark.
The Best IPOs of 2015
2015 was not a particularly strong year for IPOs, but these five did quite well.
